Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: WTDEC who wrote (21364)	5/24/1998 9:45:00 PM
From: John O'Neill	Read Replies (1) \| Respond to of 32384

WTCEC What does the expected payout in one year mean.? When would the deal close (especially is SRGN drug is approved?).....Does one have to wait a year to get LGND stock? & would one have action on LGND during that year.? Thanks JO

To: WTDEC who wrote (21364)	5/25/1998 7:52:00 AM
From: Russian Bear	Read Replies (1) \| Respond to of 32384

Thanks for your thoughts, Walter. I agree with you entirely. If it weren't for SRGN's illiquidity (and miniature market cap.,) arbitrageurs would have eliminated this inefficiency long ago. As it stands, SRGN remains a great opportunity for the small investor, although the margin requirements of "arbing" the deal by shorting LGND against SRGN are likely prohibitive. Hedge funds would not have this problem, but as you said, this opportunity is much too small for them even to bother. I have been a buyer of SRGN in my tax-sheltered accounts. Have a good holiday, RB